NMPA Approval

Recombinant Human Granulocyte Colony-stimulating Factor Injection

Approval Number

国药准字S20227008

Company华北制药金坦生物技术股份有限公司

Registration Date

May 9, 2022

Previous Approval Numbers

国药准字S19991016

Drug Information

Generic Name

重组人粒细胞刺激因子注射液

Trade Name

吉赛欣

Dosage Form

注射剂

Strength

1.0ml:300μg

Drug Type

生物制品

Registration Date

May 9, 2022

Company Information

Applicant Company

Company Name华北制药金坦生物技术股份有限公司

Company Address

石家庄高新区天山南大街106号

Manufacturing Company

Company Name华北制药金坦生物技术股份有限公司

Company Address

石家庄高新区天山南大街106号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.